000 | 01935 a2200577 4500 | ||
---|---|---|---|
005 | 20250517225200.0 | ||
264 | 0 | _c20190919 | |
008 | 201909s 0 0 eng d | ||
022 | _a1872-9096 | ||
024 | 7 |
_a10.1016/j.antiviral.2018.07.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLackenby, Angie | |
245 | 0 | 0 |
_aGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017. _h[electronic resource] |
260 |
_bAntiviral research _c09 2018 |
||
300 |
_a38-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Substitution |
650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza, Human _xepidemiology |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
650 | 0 | 4 |
_aOrthomyxoviridae _xdrug effects |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aSequence Analysis, DNA |
700 | 1 | _aBesselaar, Terry G | |
700 | 1 | _aDaniels, Rod S | |
700 | 1 | _aFry, Alicia | |
700 | 1 | _aGregory, Vicki | |
700 | 1 | _aGubareva, Larisa V | |
700 | 1 | _aHuang, Weijuan | |
700 | 1 | _aHurt, Aeron C | |
700 | 1 | _aLeang, Sook-Kwan | |
700 | 1 | _aLee, Raphael T C | |
700 | 1 | _aLo, Janice | |
700 | 1 | _aLollis, Lori | |
700 | 1 | _aMaurer-Stroh, Sebastian | |
700 | 1 | _aOdagiri, Takato | |
700 | 1 | _aPereyaslov, Dmitriy | |
700 | 1 | _aTakashita, Emi | |
700 | 1 | _aWang, Dayan | |
700 | 1 | _aZhang, Wenqing | |
700 | 1 | _aMeijer, Adam | |
773 | 0 |
_tAntiviral research _gvol. 157 _gp. 38-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.antiviral.2018.07.001 _zAvailable from publisher's website |
999 |
_c28607893 _d28607893 |